Can a serum give you fuller lashes? a trial puts it to the test

NCT ID NCT07776028

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether a cosmetic eyelash serum called Dallixa® can safely improve eyelash fullness and length in adults who have naturally sparse eyelashes (idiopathic eyelash hypotrichosis). Participants will apply the serum and be evaluated over four months using a standard scale for eyelash prominence and measurements of lash length. The study aims to see if the serum helps achieve at least a one-grade improvement in eyelash appearance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dallixa® eyelash serum, a dermo cosmetic product with herbal or vitamin ingredients
What this could lead to
If effective, this serum could offer a non-prescription option for people with naturally sparse eyelashes to achieve fuller, longer lashes.
What could go wrong
This is a small, early-stage cosmetic trial, so results may not be conclusive or widely applicable. As with any cosmetic product, there is a risk of skin irritation or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

37 people

The number who actually took part.

Started

Aug 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Individuals of any sex and at least 18 years of age 2. Subjects who have inadequate eyelashes due to natural causes (Idiopathic eyelash hypotrichosis) 3. Eyelash prominence assessment of minimal or moderate \- A score of 1 or 2 on the clinician-graded Global Eyelash Assessment (GEA) 4. Willing to complete all required study visits, procedures, and evaluations including photography. Exclusion Criteria: 1. Subjects with unequal right and left eyelashes or no visible eyelashes 2. Damage to eyelid area (scarring) that may prevent growth of eyelashes 3. Any uncontrolled systemic disease 4. Any disease, infection, or abnormality of the eye or in the area around the eye and the current use of ophthalmic medication (glaucoma, uveitis, eye infections, chronic blepharitis or severe dry eye) 5. Any ocular (eye or eyelid) surgery within 3 months or anticipated need for ocular surgery during the study (including laser, refractive, intraocular filtering surgery, blepharoplasty) 6. Any permanent eyeliner or implants of any kind, or anticipated use of false eyelashes 7. Any semi-permanent eyelash tint, dye, curl, or eyelash extension application within 3 months 8. Use of any over-the-counter or prescription eyelash growth product within 3 months 9. Use of treatments which may affect hair growth (eg, minoxidil, chemotherapy) within 6 months 10. Unable or unwilling to keep contact lenses out during product application and for 30 minutes after application 11. Severe hyperpigmentation around the eye 12. Allergy to any component of the investigational product 13. Females who are pregnant, nursing, or planning a pregnancy during the study, or who are of childbearing potential and not using a reliable method of contraception 14. Current enrollment in an investigational product or device or participation in such a study within 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypotrichosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akdeniz Üniversitesi Hastanesi

    Antalya, Antalya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.